176 related articles for article (PubMed ID: 16168512)
1. Similarities and differences between the E5 oncoproteins of bovine papillomaviruses type 1 and type 4: cytoskeleton, motility and invasiveness in E5-transformed bovine and mouse cells.
Tsirimonaki E; Ullah R; Marchetti B; Ashrafi GH; McGarry L; Ozanne B; Campo MS
Virus Res; 2006 Feb; 115(2):158-68. PubMed ID: 16168512
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins.
Ashrafi GH; Tsirimonaki E; Marchetti B; O'Brien PM; Sibbet GJ; Andrew L; Campo MS
Oncogene; 2002 Jan; 21(2):248-59. PubMed ID: 11803468
[TBL] [Abstract][Full Text] [Related]
3. An intact PDGF signaling pathway is required for efficient growth transformation of mouse C127 cells by the bovine papillomavirus E5 protein.
Riese DJ; DiMaio D
Oncogene; 1995 Apr; 10(7):1431-9. PubMed ID: 7731695
[TBL] [Abstract][Full Text] [Related]
4. Bovine papillomavirus type 1 oncoprotein E5 stimulates the utilization of superoxide radicals in the mouse fibroblast cell line C127.
Kilk A; Rausalu K; Ustav M
Chem Biol Interact; 2006 Feb; 159(3):205-12. PubMed ID: 16413007
[TBL] [Abstract][Full Text] [Related]
5. The role of exogenous p53 and E6 oncoproteins in in vitro transformation by bovine papillomavirus type 4 (BPV-4): significance of the absence of an E6 ORF in the BPV-4 genome.
Scobie L; Jackson ME; Campo MS
J Gen Virol; 1997 Nov; 78 ( Pt 11)():3001-8. PubMed ID: 9367387
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of cell transformation by papillomavirus E5 proteins.
DiMaio D; Mattoon D
Oncogene; 2001 Nov; 20(54):7866-73. PubMed ID: 11753669
[TBL] [Abstract][Full Text] [Related]
7. Transactivation of the cyclin A promoter by bovine papillomavirus type 4 E5 protein.
Grindlay GJ; Campo MS; O'Brien V
Virus Res; 2005 Mar; 108(1-2):29-38. PubMed ID: 15681052
[TBL] [Abstract][Full Text] [Related]
8. The bovine papillomavirus oncoprotein E5 retains MHC class I molecules in the Golgi apparatus and prevents their transport to the cell surface.
Marchetti B; Ashrafi GH; Tsirimonaki E; O'Brien PM; Campo MS
Oncogene; 2002 Nov; 21(51):7808-16. PubMed ID: 12420217
[TBL] [Abstract][Full Text] [Related]
9. CuZn-SOD suppresses the bovine papillomavirus-induced proliferation of fibroblasts.
Rausalu K; Karo-Astover L; Kilk A; Ustav M
APMIS; 2007 Dec; 115(12):1415-21. PubMed ID: 18184412
[TBL] [Abstract][Full Text] [Related]
10. The E5 oncoprotein of BPV-4 does not interfere with the biosynthetic pathway of non-classical MHC class I.
Araibi EH; Marchetti B; Dornan ES; Ashrafi GH; Dobromylskyj M; Ellis SA; Campo MS
Virology; 2006 Sep; 353(1):174-83. PubMed ID: 16806386
[TBL] [Abstract][Full Text] [Related]
11. c-Src activation by the E5 oncoprotein enables transformation independently of PDGF receptor activation.
Suprynowicz FA; Baege A; Sunitha I; Schlegel R
Oncogene; 2002 Mar; 21(11):1695-706. PubMed ID: 11896601
[TBL] [Abstract][Full Text] [Related]
12. The E5 gene of bovine papillomavirus type 1 is sufficient for complete oncogenic transformation of mouse fibroblasts.
Bergman P; Ustav M; Sedman J; Moreno-Lopéz J; Vennström B; Pettersson U
Oncogene; 1988 May; 2(5):453-9. PubMed ID: 2836779
[TBL] [Abstract][Full Text] [Related]
13. Different contribution of bovine papillomavirus type 1 oncoproteins to the transformation of equine fibroblasts.
Yuan Z; Gault EA; Campo MS; Nasir L
J Gen Virol; 2011 Apr; 92(Pt 4):773-83. PubMed ID: 21177927
[TBL] [Abstract][Full Text] [Related]
14. A mutational analysis of the transforming functions of the E8 protein of bovine papillomavirus type 4.
O'Brien V; Ashrafi GH; Grindlay GJ; Anderson R; Campo MS
Virology; 1999 Mar; 255(2):385-94. PubMed ID: 10069964
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the transforming functions of bovine papillomavirus type 4.
Pennie WD; Grindlay GJ; Cairney M; Campo MS
Virology; 1993 Apr; 193(2):614-20. PubMed ID: 8384749
[TBL] [Abstract][Full Text] [Related]
16. Bovine papillomavirus type 1 E6-induced sensitization to apoptosis is distinct from its transforming activity.
Liu Z; Liu Y; Hong Y; Rapp L; Androphy EJ; Chen JJ
Virology; 2002 Apr; 295(2):230-7. PubMed ID: 12033781
[TBL] [Abstract][Full Text] [Related]
17. Transformation of mortal human fibroblasts and activation of a growth inhibitory pathway by the bovine papillomavirus E5 oncoprotein.
Petti LM; Ray FA
Cell Growth Differ; 2000 Jul; 11(7):395-408. PubMed ID: 10939593
[TBL] [Abstract][Full Text] [Related]
18. Localization of bovine papillomavirus type 1 E5 protein to transformed basal keratinocytes and permissive differentiated cells in fibropapilloma tissue.
Burnett S; Jareborg N; DiMaio D
Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5665-9. PubMed ID: 1319069
[TBL] [Abstract][Full Text] [Related]
19. BPV-4 E8 transforms NIH3T3 cells, up-regulates cyclin A and cyclin A-associated kinase activity and de-regulates expression of the cdk inhibitor p27Kip1.
O'Brien V; Campo MS
Oncogene; 1998 Jul; 17(3):293-301. PubMed ID: 9690511
[TBL] [Abstract][Full Text] [Related]
20. Bovine papillomavirus type-2 DNA and expression of E5 and E7 oncoproteins in vascular tumours of the urinary bladder in cattle.
Borzacchiello G; Russo V; Spoleto C; Roperto S; Balcos L; Rizzo C; Venuti A; Roperto F
Cancer Lett; 2007 May; 250(1):82-91. PubMed ID: 17125915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
